HEALTH TIPS.: Study: Newly developed COVID vaccine from Austria could protect against omicron and other variants - targets the receptor binding domains (RBD) of the SARS-CoV-2 virus

Thursday, 7 April 2022

Study: Newly developed COVID vaccine from Austria could protect against omicron and other variants - targets the receptor binding domains (RBD) of the SARS-CoV-2 virus

Study: Newly developed COVID vaccine from Austria could protect against omicron and other variants - targets the receptor binding domains (RBD) of the SARS-CoV-2 virus

submitted by /u/shallah
[link] [comments]

from Health https://ift.tt/8mM9c6I
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)